Healthcare in 2022: what you need to know
With the Covid-19 pandemic sending shockwaves in the hospital sector, healthcare providers will continue looking for ways to slowly rebuild…
With the Covid-19 pandemic sending shockwaves in the hospital sector, healthcare providers will continue looking for ways to slowly rebuild…
Eli Lilly and Company has reported results from the BRUIN CLL-322 Phase III trial, assessing Jaypirca (pirtobrutinib), a non-covalent bruton…